Clinical trial: Renzapride therapy for constipation-predominant irritable bowel syndrome– multicenter, randomized, placebo-controlled, double-blind study in primary healthcare setting
George AM, Meyers NL & Hickling RI. (2008) Aliment Pharmacol Ther; 27:…
Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome
Tack, J., Middleton, S. J., Horne, M. C., Piessevaux, H., Bloor, J. S.,…
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome
Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D & Thomforde,…